Method for sustained and extended corneal analgesia

Details Method for sustained and extended corneal analgesia Method for sustained and extended corneal analgesia

1995-04-03

1997-03-11

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514912, A61K 3124

Patent

active

056101848

ABSTRACT:
A method for sustained and extended corneal analgesia by repeated administration of ophthalmic analgesic solutions or preparations containing ultralow nontoxic subanesthetic concentrations of local anesthetic agents. A method for corneal analgesia has a fast onset of pain relief and extended duration of the corneal analgesia for several months without accompanying toxic symptoms by administering to a patient an ophthalmic analgesic solution containing a local anesthetic agent in ultralow concentration between about 0.001% and about 0.05%.

REFERENCES:
patent: 5411738 (1995-05-01), Hind
Paul M. H. Cherry, et al., The Treatment of Pain Following Photorefractive Keratectomy, Supplement to Journal of Refractive and Corneal Surgery, vol. 10, pp. 222-225, Mar./Apr. 1994.
Verna S., et al., Pain Control After PRK: Do Topical Anesthetics Have a Role?, American Academy of Ophthalmology, Annual Meeting, p. 102, Nov. 1995.

Affiliated with

Also associated with

Rating

Method for sustained and extended corneal analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for sustained and extended corneal analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for sustained and extended corneal analgesia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-443941